MorphoSys AG - American Depositary Shares (MOR)
MOR moved a median of -0.18% 30 minutes after news, and -0.16% by the close. How MOR actually reacts to news — the realized, point-in-time move the market made, measured across 27 labeled events over the last three years with zero look-ahead.
MOR’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.17% | 20% | 25 |
| 30-min | -0.18% | 35% | 26 |
| 60-min | -0.04% | 35% | 26 |
| to close | -0.16% | 42% | 26 |
Small sample: only 27 measured events — treat these medians as indicative, not stable.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when MOR moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to MOR's baseline. Nothing else.
Recent MOR events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Merger Squeeze-Out of MorphoSys Minority Shareholders Approved at 2024 Annual General Meeting | Press release | Accesswire | — | — | |
| MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market | Press release | Business Wire | +0.00% | -0.21% | |
| Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders | Press release | Accesswire | -0.28% | +0.66% | |
| MOR STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of MorphoSys AG Is Fair to Shareholders | Press release | Business Wire | -0.28% | +0.66% | |
| MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders | Press release | Business Wire | -0.28% | +0.66% | |
| MorphoSys AG Reports First Quarter 2024 Financial Results | Press release | Business Wire | -0.09% | -1.64% | |
| MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting | Press release | Accesswire | +0.00% | +0.11% | |
| MorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis | Press release | Accesswire | -0.17% | -0.39% | |
| MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis | Press release | Business Wire | -0.17% | -0.39% | |
| MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act | Press release | Accesswire | +0.10% | -0.11% | |
| MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update | Press release | Business Wire | +0.17% | -0.06% | |
| Invitation to MorphoSys' Full Year Results 2023 Conference Call on March 14, 2024 | Press release | Accesswire | +0.06% | +0.17% | |
| MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value | Press release | Accesswire | -0.14% | -7.03% | |
| MorphoSys Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and Reduces Financial Liability | Press release | Accesswire | -0.63% | -2.77% | |
| MorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare Conference | Press release | Accesswire | +0.00% | +1.00% | |
| MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study | Press release | Business Wire | +1.17% | +14.68% | |
| Ad hoc: MorphoSys' Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction | Press release | Accesswire | -0.21% | -3.81% | |
| MorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction | Press release | Business Wire | -0.21% | -3.81% | |
| MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results | Press release | Business Wire | -0.46% | -4.76% | |
| Invitation to MorphoSys' Third Quarter and First Nine Months 2023 Financial Results Conference Call on November 16, 2023 | Press release | Accesswire | +0.26% | -1.30% | |
| MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting | Press release | Accesswire | -0.55% | -8.85% | |
| MorphoSys Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023 | Press release | Accesswire | -0.42% | +0.85% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the MOR section they belong to.
Where else MOR is measured.
MOR earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Axim Biotechnologies, Inc (AXIM) | 27 | 0.00% | 16% |
| Crescita Therapeutics Inc (CTX_TSE) | 27 | 0.00% | 22% |
| ReWalk Robotics Ltd. - Ordinary Shares (RWLK) | 27 | +0.03% | 50% |
| HYPERA SA S/ADR (HYPMY) | 26 | 0.00% | 36% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is MorphoSys AG - American Depositary Shares's median reaction calculated?
Every labeled MOR news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 27 events is what this page reports. On a sample this small (27 events), treat these medians as indicative, not stable. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does MOR's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.